Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion

Central retinal vein occlusion (CRVO) is a visually disabling condition resulting from a thrombus in the major outflow vessel of the eye. The inflammatory response in CRVO is effectively treated with a dexamethasone (DEX) intravitreal implant. Uncovering the proteome changes following DEX implant in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cehofski, Lasse Jørgensen, Kruse, Anders, Mæng, Mads Odgaard, Sejergaard, Benn Falch, Schlosser, Anders, Sorensen, Grith Lykke, Grauslund, Jakob, Honoré, Bent, Vorum, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457885/
https://www.ncbi.nlm.nih.gov/pubmed/36080454
http://dx.doi.org/10.3390/molecules27175687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457885/
https://www.ncbi.nlm.nih.gov/pubmed/36080454
http://dx.doi.org/10.3390/molecules27175687

Ejemplares similares